Original paper
Pasireotide for the prevention of pancreatic fistula after pancreatoduodenectomy: comparison with a historical cohort
Abstract
Background: Pasireotide, a somatostatin analogue, aims to reduce the risk of pancreatic fistula after pancreatoduodenectomy. Based on a reduced fistula rate (9 vs. 21%, p=0.006) in a randomized trial, we started the use of postoperative pasireotide twice daily for 7 days after pancreatoduodenectomy. Methods: All consecutive patients who underwent pancreatoduodenectomy from 2012 to 2018 were analyzed. Transition to pasireotide was in February...
Paper Details
Title
Pasireotide for the prevention of pancreatic fistula after pancreatoduodenectomy: comparison with a historical cohort
Published Date
Jan 1, 2021
Journal
Volume
23
Pages
S272 - S273
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History